PAN submits comments to CMS on Medicare Advantage data collection to improve patient outcomes and advance health equity
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
In a letter to the Centers for Medicare and Medicaid Services (CMS), the PAN Foundation recommends ways in which Medicare Advantage (MA) data collection and transparency can improve processes, including:
- Identifying and improving abuses of prior authorization
- Enhancing data collection to advance health equity
- Using MA prescription drug plans data to improve patient outcomes
Read our letter and supporting materials here: